Literature DB >> 14530125

[Seroprevalence of the human cytomegalovirus among blood donors and AIDS patients in Bamako].

Ibrahim Izetiégouma Maïga1, Anatole Tounkara, Gouantoi Coulibaly, Boureima Kouriba.   

Abstract

Our aim was to study the prevalence of the human cytomegalovirus (HCMV) among blood donors and AIDS patients and to examine a clinical correlation between AIDS and HCMV seroprevalence in Bamako (Mali, West Africa). We have used Elisa kits for detecting HIV and HCMV specific antibodies. The HCMV seroprevalence was 89% among AIDS patients, 71% among HIV-infected blood donors and 58% among HIV-uninfected blood donors. The HCMV seroprevalence rate was higher among AIDS patients than among HIV-uninfected blood donors (p=0.0000007) and than among HIV-infected blood donors (p=0.00146). There was no significant difference between the HCMV seroprevalence among HIV-infected blood donors and among HIV-uninfected blood donors (p=0.0547). There was no relationship between HCMV seroprevalence and sex or age among AIDS patients and blood donors. There was a significant difference on pneumonia among HCMV-infected AIDS patients and among HCMV-uninfected AIDS patients (40% versus 0%; p=0.005). Buccal and phaiyngal candidosis, dermatosis, Kaposi's sarcoma and nervous system diseases had the same frequency among HCMV-infected and HCMV-uninfected AIDS patients.

Entities:  

Mesh:

Year:  2003        PMID: 14530125

Source DB:  PubMed          Journal:  Sante        ISSN: 1157-5999


  2 in total

1.  Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen.

Authors:  Matthew Bates; Arne Broch Brantsaeter
Journal:  J Virus Erad       Date:  2016-07-01

2.  Seroprevalence of Cytomegalovirus Infection Among HIV-Infected and HIV-Uninfected Pregnant Women Attending Antenatal Clinic in Harare, Zimbabwe.

Authors:  Doreen Mhandire; Kerina Duri; Mamadou Kaba; Kudakwashe Mhandire; Cuthbert Musarurwa; Emile Chimusa; Privilege Munjoma; Lovemore Mazengera; Babill Stray-Pedersen; Collet Dandara
Journal:  Viral Immunol       Date:  2019-07-26       Impact factor: 2.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.